Pain Medicine · Evansville, IN
NPI
1902250475
Since 2016
Specialty
Pain Medicine
Code 208VP0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
700 Kimber Lane
Evansville, IN, 47715
Phone (812) 476-7111
Groups this clinician bills Medicare through
Medicare paid, 2024
$521K
12,153 services
Medicare patients, 2024
1,217
Average age 70
Drug cost, 2024
$405K
8,682 prescriptions
Company payments, 2025
$314
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Katherine Williams was code J3301 (injection, triamcinolone acetonide, not otherwise specified, 10 mg), 1,635 times for 170 patients. In total Katherine Williams billed 12,153 services in 74 codes, and Medicare paid $521K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-11.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,635 | 170 | $0.69 | $1,136 |
| 99214 Office E&M - Established | Office | 1,612 | 852 | $87.56 | $141K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,590 | 802 | $12.36 | $20K |
| 99213 Office E&M - Established | Office | 1,056 | 626 | $60.27 | $64K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 686 | 49 | $0.08 | $58.22 |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 369 | 143 | $5.04 | $1,860 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 272 | 57 | $44.95 | $12K |
| 80307 Drug Tests | Office | 249 | 233 | $59.47 | $15K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 154 | 41 | $34.74 | $5,350 |
| 77002 Imaging - Miscellaneous | Office | 151 | 75 | $72.11 | $11K |
| 20610 Joint Injection | Office | 142 | 68 | $53.08 | $7,538 |
| 99204 Office E&M - New | Office | 139 | 139 | $107.63 | $15K |
| 64493 Nerve Block Injection - Back | Office | 112 | 63 | $170.25 | $19K |
| 64494 Nerve Block Injection - Back | Office | 109 | 62 | $90.66 | $9,882 |
| 27096 Joint Injection | Office | 99 | 67 | $130.82 | $13K |
By year: 2022 $442K for 9,588 services; 2023 $499K for 10,487 services; 2024 $521K for 12,153 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 249 | 233 | $59.47 | $15K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 76 | 76 | $241.98 | $18K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 70 | 67 | $153.46 | $11K |
Medicare prescription drug claims, 2024
In 2024, the drug Katherine Williams prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 2,579 prescriptions and refills. In total Katherine Williams wrote 8,682 Medicare prescriptions that cost $405K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 2,579 | 2,580 | 603 | $74K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,436 | 2,436 | 844 | $55K |
| Gabapentin Generic | 1,032 | 1,116 | 402 | $9,523 |
| Pregabalin Generic | 382 | 394 | 170 | $7,918 |
| Oxycodone Hcl Generic | 349 | 349 | 95 | $8,904 |
| Tramadol Hcl Generic | 189 | 189 | 97 | $1,190 |
| Buprenorphine Generic | 178 | 178 | 78 | $53K |
| Morphine Sulfate Er Morphine Sulfate | 169 | 169 | 32 | $4,142 |
| Tizanidine Hcl Generic | 123 | 156 | 69 | $984 |
| Hydromorphone Hcl Generic | 118 | 118 | 41 | $2,861 |
| Belbuca Buprenorphine Hcl | 101 | 101 | 35 | $79K |
| Cyclobenzaprine Hcl Generic | 94 | 96 | 51 | $659 |
| Fentanyl Generic | 80 | 80 | 16 | $14K |
| Meloxicam Generic | 69 | 73 | 36 | $2,009 |
| Methocarbamol Generic | 62 | 62 | 45 | $438 |
Brand drugs: 351 claims; generic drugs: 8,331 claims; opioid claims: 6,418.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Katherine Williams $314 ($314 in general payments such as food, travel and fees) from 8 companies. The largest payer was Abbvie Inc. with $89.62.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 5 | $89.62 |
| Vertex Pharmaceuticals Incorporated VRTX | 2 | $54.33 |
| Abbott Laboratories ABT | 3 | $51.5 |
| TerSera Therapeutics LLC | 2 | $46.75 |
| Valinor Pharma, LLC | 1 | $20.71 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $19.96 |
| Collegium Pharmaceutical, Inc. COLL | 1 | $17.78 |
| Boston Scientific Corporation BSX | 1 | $13.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.